Systematic Alpha Investments’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-3,001
Closed -$788K 306
2022
Q4
$788K Hold
3,001
0.04% 107
2022
Q3
$676K Buy
+3,001
New +$727K 0.04% 105
2021
Q4
Sell
-1
Closed 243
2021
Q3
$0 Hold
1
﹤0.01% 481
2021
Q2
$0 Sell
1
-599
-100% -$147K ﹤0.01% 315
2021
Q1
$149K Hold
600
0.01% 136
2020
Q4
$138K Buy
+600
New +$138K 0.02% 106

Other funds holding AMGN

Systematic Alpha Investments's AMGN Position: Q1 2023 in Review

Systematic Alpha Investments sold out of Amgen (AMGN) in Q1 2023, closing a stake of 3,001 shares — an estimated $788K sold.

Systematic Alpha Investments first reported a position in AMGN in Q4 2020 and held it in 6 quarters. The position peaked at $788K in Q4 2022. 2,435 funds tracked by Wall St. Rank hold AMGN as of Q1 2023.

  • Systematic Alpha Investments reported no remaining Amgen position as of Q1 2023 after selling out during the quarter.
  • Systematic Alpha Investments sold 3,001 Amgen shares in Q1 2023, an estimated $788K.
  • Systematic Alpha Investments first reported a position in Amgen in Q4 2020 and held it in 6 quarters.
  • Systematic Alpha Investments's Amgen position peaked at $788K in Q4 2022.
  • 2,435 funds tracked by Wall St. Rank held Amgen as of Q1 2023.

Based on Systematic Alpha Investments's 13F filing for Q1 2023, filed 15 May 2023.